Monday, February 13, 2017

Prostate Cancer and Prostatic Diseases - Table of Contents alert Volume 20 Issue 1

If you are unable to see the message below, click here to view.
Prostate Cancer and Prostatic Diseases


Volume 20, Issue 1 (March 2017)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Follow PCAN on Twitter Twitter
Recommend to your library
Web feed



Active surveillance for intermediate-risk prostate cancer

M A Dall'Era and L Klotz

Prostate Cancer Prostatic Dis 2017 20: 1-6; advance online publication, November 1, 2016; 10.1038/pcan.2016.51

Abstract | Full Text

The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients

M Moschini, F Soria, A Briganti and S F Shariat

Prostate Cancer Prostatic Dis 2017 20: 7-11; advance online publication, October 25, 2016; 10.1038/pcan.2016.52

Abstract | Full Text

Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions

R J Hendriks, I M van Oort and J A Schalken

Prostate Cancer Prostatic Dis 2017 20: 12-19; advance online publication, December 6, 2016; 10.1038/pcan.2016.59

Abstract | Full Text

Original Articles


Role of OATP transporters in steroid uptake by prostate cancer cells in vivo

S M Green, A Kaipainen, K Bullock, A Zhang, J M Lucas, C Matson, W A Banks and E A Mostaghel

Prostate Cancer Prostatic Dis 2017 20: 20-27; advance online publication, September 20, 2016; 10.1038/pcan.2016.42

Abstract | Full Text

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

B Benzon, S G Zhao, M C Haffner, M Takhar, N Erho, K Yousefi, P Hurley, J L Bishop, J Tosoian, K Ghabili, M Alshalalfa, S Glavaris, B W Simons, P Tran, E Davicioni, R J Karnes, K Boudadi, E S Antonarakis, E M Schaeffer, C G Drake, F Feng and A E Ross

Prostate Cancer Prostatic Dis 2017 20: 28-35; advance online publication, November 1, 2016; 10.1038/pcan.2016.49

Abstract | Full Text

SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma

A Villalobos-Hernandez, D Bobbala, R Kandhi, M G M Khan, M Mayhue, C M Dubois, G Ferbeyre, C Saucier, S Ramanathan and S Ilangumaran

Prostate Cancer Prostatic Dis 2017 20: 36-47; advance online publication, October 25, 2016; 10.1038/pcan.2016.50

Abstract | Full Text

Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project

E H Allott, L Arab, L J Su, L Farnan, E T H Fontham, J L Mohler, J T Bensen and S E Steck

Prostate Cancer Prostatic Dis 2017 20: 48-54; advance online publication, September 6, 2016; 10.1038/pcan.2016.39

Abstract | Full Text

Does prostate volume correlate with vitamin D deficiency among men undergoing prostate biopsy?

A B Murphy, Y A Nyame, K Batai, R Kalu, A Khan, P Gogana, M Dixon, V Macias, A Kajdacsy-Balla, C M P Hollowell, W J Catalona and R Kittles

Prostate Cancer Prostatic Dis 2017 20: 55-60; advance online publication, October 11, 2016; 10.1038/pcan.2016.41

Abstract | Full Text

Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study

B Hager, K Kraywinkel, B Keck, A Katalinic, M Meyer, S R Zeissig, R Scheufele, M P Wirth and J Huber

Prostate Cancer Prostatic Dis 2017 20: 61-66; advance online publication, September 13, 2016; 10.1038/pcan.2016.43

Abstract | Full Text

Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer

G Sonpavde, G R Pond, A J Templeton, E D Kwon and J S De Bono

Prostate Cancer Prostatic Dis 2017 20: 67-71; advance online publication, September 27, 2016; 10.1038/pcan.2016.44

Abstract | Full Text

Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database OPEN

A C Vidal, L E Howard, S X Sun, M R Cooperberg, C J Kane, W J Aronson, M K Terris, C L Amling and S J Freedland

Prostate Cancer Prostatic Dis 2017 20: 72-78; advance online publication, October 4, 2016; 10.1038/pcan.2016.47

Abstract | Full Text

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death

N N Sanford, M-H Chen, M Loffredo, A Renshaw, P W Kantoff and A V D'Amico

Prostate Cancer Prostatic Dis 2017 20: 79-84; advance online publication, November 8, 2016; 10.1038/pcan.2016.53

Abstract | Full Text

The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer

D Porres, D Pfister, A Thissen, T H Kuru, V Zugor, R Buettner, R Knuechel, F A Verburg and A Heidenreich

Prostate Cancer Prostatic Dis 2017 20: 85-92; advance online publication, November 8, 2016; 10.1038/pcan.2016.54

Abstract | Full Text

The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer

W S Jang, C Y Yoon, M S Kim, D H Kang, Y J Kang, W S Jeong, M J Abalajon, W S Ham and Y D Choi

Prostate Cancer Prostatic Dis 2017 20: 93-98; advance online publication, November 15, 2016; 10.1038/pcan.2016.55

Abstract | Full Text

Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population

P K Chiu, M J Roobol, D Nieboer, J Y Teoh, S K Yuen, S M Hou, M K Yiu and C F Ng

Prostate Cancer Prostatic Dis 2017 20: 99-104; advance online publication, November 29, 2016; 10.1038/pcan.2016.57

Abstract | Full Text

Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy

D P Nguyen, M Kent, A Vilaseca, R B Corradi, N Fossati, D D Sjoberg, N Benfante, J A Eastham, P T Scardino and K A Touijer

Prostate Cancer Prostatic Dis 2017 20: 105-109; advance online publication, December 13, 2016; 10.1038/pcan.2016.60

Abstract | Full Text

Skeletal-related events significantly impact health-related quality of life in metastatic castration-resistant prostate cancer: data from PREVAIL and AFFIRM trials OPEN

F Saad, C Ivanescu, D Phung, Y Loriot, S Abhyankar, T M Beer, B Tombal and S Holmstrom

Prostate Cancer Prostatic Dis 2017 20: 110-116; advance online publication, January 3, 2017; 10.1038/pcan.2016.62

Abstract | Full Text

Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis

M Moschini, A Morlacco, E Kwon, L J Rangel and R J Karnes

Prostate Cancer Prostatic Dis 2017 20: 117-121; advance online publication, January 3, 2017; 10.1038/pcan.2016.63

Abstract | Full Text

Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study

C B Chen, D T Eurich, S R Majumdar and J A Johnson

Prostate Cancer Prostatic Dis 2017 20: 122-126; advance online publication, January 10, 2017; 10.1038/pcan.2016.65

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: